| 标题 |
Class III β-Tubulin Expression Is of Value in Selecting nab-Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Pancreas 作者:Akihisa Kato; Itaru Naitoh; Aya Naiki-Ito; Kazuki Hayashi; Fumihiro Okumura; et al 出版日期:2022 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)